What's next after 50 years of psychiatric drug development: an FDA perspective.
Laughren
Thomas P
TP
Division of Psychiatry Products, Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA. thomas.laughren@fda.hhs.gov